|
JPH0329734A
(ja)
|
1989-06-20 |
1991-02-07 |
Kubota Corp |
ラベルプリンタ
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US20050276784A1
(en)
|
1990-08-27 |
2005-12-15 |
Solan-Kettering Institute For Cancer Research |
Ligand for the c-kit receptor and methods of use thereof
|
|
DE4205148A1
(de)
|
1991-05-25 |
1993-01-21 |
Boehringer Mannheim Gmbh |
Monoklonale antikoerper gegen c-kit
|
|
WO1994008039A1
(en)
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
|
US5821108A
(en)
|
1995-04-07 |
1998-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
|
|
US6429025B1
(en)
|
1996-06-28 |
2002-08-06 |
Caliper Technologies Corp. |
High-throughput screening assay systems in microscale fluidic devices
|
|
WO1999019500A1
(en)
|
1997-10-10 |
1999-04-22 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Healt H And Human Services |
Complex of biotinylated viral vector and ligand for targeted gene delivery
|
|
WO1999061584A1
(en)
|
1998-05-29 |
1999-12-02 |
Thomas Jefferson University |
Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
|
|
US6607891B1
(en)
|
1998-07-31 |
2003-08-19 |
Mitsubishi Chemical Corporation |
Method of assaying insulin-like growth factor
|
|
US6989248B2
(en)
|
1999-05-06 |
2006-01-24 |
The Trustees Of Columbia University In The City Of New York |
Methods of use of compounds which inhibit the stem cell signaling pathway
|
|
CA2392490A1
(en)
|
1999-11-24 |
2001-05-31 |
Mcs Micro Carrier Systems Gmbh |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
US20030082155A1
(en)
|
1999-12-06 |
2003-05-01 |
Habener Joel F. |
Stem cells of the islets of langerhans and their use in treating diabetes mellitus
|
|
US7862810B2
(en)
|
2000-07-31 |
2011-01-04 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US20040003420A1
(en)
|
2000-11-10 |
2004-01-01 |
Ralf Kuhn |
Modified recombinase
|
|
US20050222030A1
(en)
|
2001-02-21 |
2005-10-06 |
Anthony Allison |
Modified annexin proteins and methods for preventing thrombosis
|
|
US20040115184A1
(en)
|
2001-02-27 |
2004-06-17 |
Smith Harold C |
Methods and compositions for modifying apolipoprotein b mrna editing
|
|
EP1391505B1
(en)
|
2001-04-24 |
2009-01-28 |
Ajinomoto Co., Inc. |
Stem cells and method of separating the same
|
|
CA2449042A1
(en)
|
2001-05-30 |
2002-12-27 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
EP2277991A1
(en)
|
2001-08-21 |
2011-01-26 |
Ventana Medical Systems, Inc. |
Method and quantification assay for determining c-kit/SCF/pAKT status
|
|
WO2003042405A2
(en)
|
2001-11-15 |
2003-05-22 |
Children's Medical Center Corporation |
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
|
|
AU2003219718A1
(en)
|
2002-02-06 |
2003-09-02 |
Orbus Medical Technologies Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US20040161419A1
(en)
|
2002-04-19 |
2004-08-19 |
Strom Stephen C. |
Placental stem cells and uses thereof
|
|
EP1622645B1
(en)
|
2002-04-23 |
2013-10-23 |
Roger Williams Hospital |
Compositions and methods for stem cell delivery
|
|
US20040005623A1
(en)
|
2002-06-10 |
2004-01-08 |
Longley B. Jack |
Method of determining tumor sensitivities to therapeutic drugs
|
|
WO2004002425A2
(en)
|
2002-06-28 |
2004-01-08 |
Bio Transplant, Inc. |
Process for promoting graft acceptance by depletion of hematopoietic stem cells
|
|
US20060034767A1
(en)
|
2002-07-05 |
2006-02-16 |
Roger Williams Medical Center |
Targeting and tracking of cells to specific organs and tissues in vivo
|
|
US20050032122A1
(en)
|
2003-08-06 |
2005-02-10 |
Shiaw-Min Hwang |
Optimizing culture medium for CD34<+> hematopoietic cell expansion
|
|
US20050124896A1
(en)
|
2003-08-25 |
2005-06-09 |
Jacob Richter |
Method for protecting implantable sensors and protected implantable sensors
|
|
EP1682181A2
(en)
|
2003-09-23 |
2006-07-26 |
Novartis AG |
Combination of a vegf receptor inhibitor with a chemotherapeutic agent
|
|
TWI338714B
(en)
|
2003-12-02 |
2011-03-11 |
Cathay General Hospital |
Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
|
|
CA2556018A1
(en)
|
2004-02-11 |
2005-09-09 |
Aldagen, Inc. |
Stem cell populations and methods of use
|
|
US20050187607A1
(en)
|
2004-02-20 |
2005-08-25 |
Akhtar Adil J. |
Drug delivery device
|
|
US8603763B2
(en)
|
2004-04-08 |
2013-12-10 |
Cornell Research Foundation, Inc. |
Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
|
|
US7910315B2
(en)
|
2004-09-10 |
2011-03-22 |
The Regents Of The University Of Colorado, A Body Corporate |
Early detection of hemangiosarcoma and angiosarcoma
|
|
WO2006062946A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Florida Research Foundation, Inc. |
Incorporation of bone marrow derived stem cells in tumors
|
|
AU2006203990B2
(en)
|
2005-01-07 |
2011-08-11 |
Wake Forest University Health Sciences |
Regeneration of pancreatic islets by amniotic fluid stem cell therapy
|
|
US20080248503A1
(en)
|
2005-02-16 |
2008-10-09 |
Rich Ivan N |
Methods of Screening Compounds to Predict Toxicity and Residual Proliferative and Differentiation Capacity of the Lympho-Hematopoietic System
|
|
US20060222634A1
(en)
|
2005-03-31 |
2006-10-05 |
Clarke Diana L |
Amnion-derived cell compositions, methods of making and uses thereof
|
|
JP5129122B2
(ja)
|
2005-04-26 |
2013-01-23 |
トリオン ファーマ ゲーエムベーハー |
癌治療のための抗体およびグルココルチコイドの組み合わせ
|
|
US20070041948A1
(en)
|
2005-07-20 |
2007-02-22 |
Seoul National University Industry Foundation |
Method for culturing and proliferating hematopoietic stem cells and progenitor cells using human endometrial cells
|
|
EP3061834B1
(en)
|
2005-10-21 |
2020-01-08 |
The Regents of the University of California |
Shp-2 gene mutations in melanoma
|
|
JPWO2007052849A1
(ja)
|
2005-11-07 |
2009-04-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
血管新生阻害物質とｃ−ｋｉｔキナーゼ阻害物質との併用
|
|
WO2007084949A2
(en)
|
2006-01-18 |
2007-07-26 |
The Uab Research Foundation |
Modulators of cardiac cell hypertrophy and hyperplasia
|
|
US20070254319A1
(en)
|
2006-04-07 |
2007-11-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of a constitutively resistant cancer stem cell
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
US8568286B2
(en)
|
2006-06-14 |
2013-10-29 |
Cardiac Pacemakers, Inc. |
Methods to position therapeutic agents using a magnetic field
|
|
WO2008067115A2
(en)
|
2006-11-03 |
2008-06-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective immunodepletion of endogenous stem cell niche for engraftment
|
|
US20100143935A1
(en)
|
2006-12-01 |
2010-06-10 |
Apocell, Inc. |
c-KIT Phosphorylation in Cancer
|
|
WO2008076143A1
(en)
|
2006-12-18 |
2008-06-26 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
|
WO2008085951A2
(en)
|
2007-01-04 |
2008-07-17 |
Vivek Mittal |
Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
|
|
DE102007008650B4
(de)
|
2007-02-20 |
2012-06-06 |
Charité - Universitätsmedizin Berlin |
Zellen zur Therapie des Herzens
|
|
CN102851254A
(zh)
|
2007-03-01 |
2013-01-02 |
干细胞国际公司 |
制备、分离及超低温保存子宫内膜/月经细胞
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
WO2009058983A2
(en)
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
|
US20090169613A1
(en)
|
2007-11-09 |
2009-07-02 |
Reznik Boris N |
Targeting of tumor stem cells through selective silencing of boris expression
|
|
CN102203131A
(zh)
|
2008-10-22 |
2011-09-28 |
霍夫曼-拉罗奇有限公司 |
前列腺干细胞及其用途
|
|
EP2995953B1
(en)
|
2009-03-24 |
2017-11-29 |
Biocept, Inc. |
Devices and methods of cell capture and analysis
|
|
CN102481340A
(zh)
|
2009-05-28 |
2012-05-30 |
葛兰素集团有限公司 |
干细胞靶向
|
|
EP2259065A1
(en)
|
2009-06-03 |
2010-12-08 |
Erasmus University Medical Center Rotterdam |
Methods, reagents and kits for flow cytometric immunophenotyping
|
|
WO2013166281A1
(en)
|
2012-05-02 |
2013-11-07 |
Cedars-Sinai Medical Center |
Bi-functional compositions for targeting cells to diseased tissues and methods of using same
|
|
US20110104787A1
(en)
|
2009-11-05 |
2011-05-05 |
President And Fellows Of Harvard College |
Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
|
|
US9149544B2
(en)
|
2009-11-06 |
2015-10-06 |
The Penn State Research Foundation |
Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo
|
|
US8518716B2
(en)
|
2009-11-30 |
2013-08-27 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Soluble CD117 (sc-kit) for diagnosis of preeclampsia and eclampsia
|
|
WO2011073521A1
(en)
|
2009-12-15 |
2011-06-23 |
Petri Salven |
Methods for enriching adult-derived endothelial progenitor cells and uses thereof
|
|
JP2013514779A
(ja)
|
2009-12-18 |
2013-05-02 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
脱メチル化および細胞の再プログラミングを促進するためのシチジンデアミナーゼ関連薬剤の使用
|
|
MX2012008153A
(es)
|
2010-01-12 |
2012-11-06 |
Nestec Sa |
Metodos para predecir la respuesta a terapia de cancer de mama triple negativo.
|
|
WO2012004778A1
(en)
|
2010-07-09 |
2012-01-12 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for in-vitro monitoring of neuronal disorders and use thereof
|
|
EP2624847B1
(en)
|
2010-10-05 |
2017-09-13 |
AAL Scientifics, Inc. |
Human lung stem cells and uses thereof
|
|
WO2012068243A2
(en)
|
2010-11-16 |
2012-05-24 |
Ingeneron, Inc. |
Methods for obtaining target cells
|
|
WO2012068248A2
(en)
|
2010-11-16 |
2012-05-24 |
Ingeneron, Inc. |
Methods for preserving target cells
|
|
WO2012135844A2
(en)
|
2011-04-01 |
2012-10-04 |
Cornell University |
Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers
|
|
TW201303295A
(zh)
|
2011-04-15 |
2013-01-16 |
克雷維斯製藥公司 |
偵測血液失調中之人平衡型核苷轉運蛋白１（ｈＥＮＴ１）表現用之系統和方法
|
|
JP2014523518A
(ja)
|
2011-05-11 |
2014-09-11 |
ステムラド リミテッド |
放射線防護装置及びその方法
|
|
AR086044A1
(es)
|
2011-05-12 |
2013-11-13 |
Imclone Llc |
Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos
|
|
CA2806625A1
(en)
|
2011-06-14 |
2012-12-20 |
Mickie Bhatia |
Isolated embryonic stem cells that express lineage markers and associated methods
|
|
CN102876666B
(zh)
|
2011-07-15 |
2015-02-04 |
内蒙古弘泰医学科技有限公司 |
Rna胞体及其用途
|
|
CN103088008B
(zh)
|
2011-10-31 |
2014-08-20 |
中国科学院微生物研究所 |
胞苷脱氨酶及其编码基因和它们的应用
|
|
CN104284669A
(zh)
|
2012-02-24 |
2015-01-14 |
弗雷德哈钦森癌症研究中心 |
治疗血红蛋白病的组合物和方法
|
|
KR101384360B1
(ko)
|
2012-05-04 |
2014-04-14 |
아주대학교산학협력단 |
Ｓｃｆ 또는 이의 수용체를 억제하는 물질을 포함하는 혈관 투과성 관련 질환의 치료 또는 예방용 조성물
|
|
PL4289948T3
(pl)
|
2012-05-25 |
2025-06-02 |
The Regents Of The University Of California |
Sposoby i kompozycje do modyfikacji kierowanego na rna docelowego dna i do nakierowanej na rna modulacji transkrypcji
|
|
US9102936B2
(en)
|
2012-06-11 |
2015-08-11 |
Agilent Technologies, Inc. |
Method of adaptor-dimer subtraction using a CRISPR CAS6 protein
|
|
JP6262218B2
(ja)
|
2012-06-14 |
2018-01-17 |
エラスムス ユニバーシティ メディカルセンター ロッテルダムＥｒａｓｍｕｓ Ｕｎｉｖｅｒｓｉｔｙ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ Ｒｏｔｔｅｒｄａｍ |
微小残存病変を検出するための方法、試薬およびキット。
|
|
CA2877882A1
(en)
|
2012-06-27 |
2014-01-03 |
The Trustees Of Princeton University |
Split inteins, conjugates and uses thereof
|
|
PL2890780T3
(pl)
|
2012-08-29 |
2021-02-08 |
Sangamo Therapeutics, Inc. |
Sposoby i kompozycje do leczenia zaburzeń genetycznych
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
WO2014043442A1
(en)
|
2012-09-14 |
2014-03-20 |
Children's Medical Center Corporation |
Inhibition of viral infection-triggered asthma with c-kit inhibitor
|
|
AU2013331154B2
(en)
|
2012-10-17 |
2018-02-01 |
Cedars-Sinai Medical Center |
Molecular signatures of ovarian cancer
|
|
WO2014066271A1
(en)
|
2012-10-22 |
2014-05-01 |
Becton, Dickinson And Company |
Non-b-lineage cells capable of producing antibody
|
|
EP2914273B1
(en)
|
2012-10-26 |
2018-07-04 |
Cedars-Sinai Medical Center |
Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair of regeneration
|
|
EP2922827A4
(en)
|
2012-11-20 |
2016-06-08 |
Celgene Avilomics Res Inc |
METHOD FOR THE TREATMENT OF A DISEASE OR DISEASE RELATED TO BRUTON TYROSINE KINASE
|
|
CN105142669B
(zh)
|
2012-12-06 |
2018-07-03 |
西格马-奥尔德里奇有限责任公司 |
基于crispr的基因组修饰和调控
|
|
WO2014093655A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
WO2014093622A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
|
|
EP4282970A3
(en)
|
2012-12-17 |
2024-01-17 |
President and Fellows of Harvard College |
Rna-guided human genome engineering
|
|
US20210137991A1
(en)
|
2013-02-08 |
2021-05-13 |
Themba Inc. |
Gene editing for autoimmune disorders
|
|
EP2970985A1
(en)
|
2013-03-14 |
2016-01-20 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
IL289396B2
(en)
|
2013-03-15 |
2023-12-01 |
The General Hospital Coporation |
Using truncated guide rnas (tru-grnas) to increase specificity for rna-guided genome editing
|
|
WO2014141306A2
(en)
|
2013-03-15 |
2014-09-18 |
Rajiv Gandhi Centre For Biotechnology |
Methods and materials for identifying therapeutic response in chronic myeloid leukemia
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
WO2014186686A2
(en)
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
|
US20140356956A1
(en)
|
2013-06-04 |
2014-12-04 |
President And Fellows Of Harvard College |
RNA-Guided Transcriptional Regulation
|
|
KR102307280B1
(ko)
*
|
2013-06-05 |
2021-10-01 |
듀크 유니버시티 |
Rna-가이드 유전자 편집 및 유전자 조절
|
|
WO2014197821A1
(en)
|
2013-06-06 |
2014-12-11 |
President And Fellows Of Harvard College |
Homeodomain fusion proteins and uses thereof
|
|
EP3019595A4
(en)
|
2013-07-09 |
2016-11-30 |
|
THERAPEUTIC USES OF A GENERIC CHANGE WITH CRISPR / CAS SYSTEMS
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
DK3019619T3
(da)
|
2013-07-11 |
2021-10-11 |
Modernatx Inc |
Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
|
|
US20150044772A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
Crispr/cas system-based novel fusion protein and its applications in genome editing
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
JP2016536021A
(ja)
|
2013-11-07 |
2016-11-24 |
エディタス・メディシン，インコーポレイテッド |
ＣＲＩＳＰＲ関連方法および支配ｇＲＮＡのある組成物
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
US9994831B2
(en)
|
2013-12-12 |
2018-06-12 |
The Regents Of The University Of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
|
EP3080271B1
(en)
|
2013-12-12 |
2020-02-12 |
The Broad Institute, Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
|
EP3653229A1
(en)
|
2013-12-12 |
2020-05-20 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing
|
|
WO2015148512A1
(en)
|
2014-03-24 |
2015-10-01 |
Qt Holdings Corp |
Shaped articles including hydrogels and methods of manufacture and use thereof
|
|
CA2943365A1
(en)
|
2014-04-01 |
2015-10-08 |
Childrens Hospital Los Angeles |
Targeted polymerized nanoparticles for cancer treatment
|
|
CA2951707A1
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
ES2845898T5
(en)
|
2014-08-26 |
2025-06-17 |
Univ Leland Stanford Junior |
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
|
|
US10450584B2
(en)
|
2014-08-28 |
2019-10-22 |
North Carolina State University |
Cas9 proteins and guiding features for DNA targeting and genome editing
|
|
EP2995948A1
(en)
|
2014-09-09 |
2016-03-16 |
Ecole Polytechnique Federale de Lausanne (EPFL) |
Methods and compounds useful in hematopoietic stem cell medicine
|
|
WO2016049258A2
(en)
|
2014-09-25 |
2016-03-31 |
The Broad Institute Inc. |
Functional screening with optimized functional crispr-cas systems
|
|
CN108064282A
(zh)
|
2014-10-14 |
2018-05-22 |
哈洛齐梅公司 |
腺苷脱氨酶-2(ada2)、其变体的组合物及使用其的方法
|
|
US11071790B2
(en)
|
2014-10-29 |
2021-07-27 |
Massachusetts Eye And Ear Infirmary |
Method for efficient delivery of therapeutic molecules in vitro and in vivo
|
|
DK3216867T3
(da)
|
2014-11-04 |
2020-06-22 |
Univ Kobe Nat Univ Corp |
Fremgangsmåde til at modificere genomsekvens for at introducere specifik mutation i tilsigtet dna-sekvens ved base-fjernelsesreaktion og molekylekompleks anvendt dertil
|
|
US10191055B2
(en)
|
2014-11-26 |
2019-01-29 |
Oxford University Innovation Limited |
Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC)
|
|
EP3230452B1
(en)
|
2014-12-12 |
2025-06-11 |
The Broad Institute, Inc. |
Dead guides for crispr transcription factors
|
|
CA2968336C
(en)
|
2014-12-17 |
2021-11-23 |
Proqr Therapeutics Ii B.V. |
Construct for site directed editing of an adenosine nucleotide in target rna
|
|
BR112017017810A2
(pt)
|
2015-02-23 |
2018-04-10 |
Crispr Therapeutics Ag |
materiais e métodos para tratamento de hemoglobinopatias
|
|
US12129471B2
(en)
|
2015-02-23 |
2024-10-29 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
WO2016141224A1
(en)
|
2015-03-03 |
2016-09-09 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
|
WO2016149682A2
(en)
|
2015-03-18 |
2016-09-22 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for targeting cd99 in haematopoietic and lymphoid malignancies
|
|
EP3280720A4
(en)
|
2015-04-06 |
2018-12-05 |
President and Fellows of Harvard College |
Compositions and methods for non-myeloablative conditioning
|
|
AU2016262521A1
(en)
|
2015-05-11 |
2017-12-14 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for treating HIV infection and AIDS
|
|
CN106011104B
(zh)
|
2015-05-21 |
2019-09-27 |
清华大学 |
利用拆分Cas系统进行基因编辑和表达调控方法
|
|
US9957501B2
(en)
|
2015-06-18 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
EP3957731A1
(en)
|
2015-07-15 |
2022-02-23 |
Rutgers, The State University of New Jersey |
Nuclease-independent targeted gene editing platform and uses thereof
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US11008555B2
(en)
|
2015-09-17 |
2021-05-18 |
The Regents Of The University Of California |
Variant Cas9 polypeptides comprising internal insertions
|
|
EP3356520B1
(en)
|
2015-10-02 |
2022-03-23 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Lentiviral protein delivery system for rna-guided genome editing
|
|
EP4434589A3
(en)
|
2015-10-23 |
2025-05-14 |
President and Fellows of Harvard College |
Evolved cas9 proteins for gene editing
|
|
ES2942309T3
(es)
|
2015-11-04 |
2023-05-31 |
Vertex Pharma |
Materiales y métodos para el tratamiento de hemoglobinopatías
|
|
WO2017077386A1
(en)
|
2015-11-06 |
2017-05-11 |
Crispr Therapeutics Ag |
Materials and methods for treatment of glycogen storage disease type 1a
|
|
JP6932698B2
(ja)
|
2015-12-01 |
2021-09-08 |
クリスパー・セラピューティクス・アクチェンゲゼルシャフトＣＲＩＳＰＲ Ｔｈｅｒａｐｅｕｔｉｃｓ ＡＧ |
アルファ１アンチトリプシン欠乏症の治療のための材料および方法
|
|
KR102723347B1
(ko)
|
2016-03-14 |
2024-10-28 |
에디타스 메디신, 인코포레이티드 |
베타 이상헤모글로빈증의 치료를 위한 crispr/cas-관련 방법 및 조성물
|
|
WO2017165862A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
SMT202500211T1
(it)
|
2016-03-30 |
2025-07-22 |
Intellia Therapeutics Inc |
Formulazioni di nanoparticelle lipidiche per componenti crispr/cas
|
|
EP4711465A2
(en)
|
2016-04-14 |
2026-03-18 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
JP2019103391A
(ja)
|
2016-04-14 |
2019-06-27 |
国立大学法人 東京医科歯科大学 |
単球系統のみに分化するヒト単球前駆細胞およびその単離方法
|
|
WO2017189308A1
(en)
|
2016-04-19 |
2017-11-02 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
|
KR20260004568A
(ko)
|
2016-04-19 |
2026-01-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규한 crispr 효소 및 시스템
|
|
WO2017191503A1
(en)
|
2016-05-05 |
2017-11-09 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
FR3051555B1
(fr)
|
2016-05-20 |
2018-05-11 |
Horiba Abx Sas |
Detection de la maladie residuelle du myelome multiple
|
|
MX2018014577A
(es)
|
2016-05-27 |
2019-05-20 |
Tg Therapeutics Inc |
Combinacion de anticuerpo anti-cd20, inhibidor selectivo de quinasa p13-delta, e inhibidor de btk para tratar trastornos proliferativos de celulas b.
|
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
|
AU2017204139B2
(en)
|
2016-06-17 |
2018-08-09 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for the depletion of cells
|
|
KR20230066647A
(ko)
|
2016-06-17 |
2023-05-16 |
마젠타 테라퓨틱스 인코포레이티드 |
Cd117+ 세포의 고갈을 위한 조성물 및 방법
|
|
WO2018020323A2
(en)
|
2016-07-25 |
2018-02-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of fatty acid disorders
|
|
JP7231935B2
(ja)
*
|
2016-08-03 |
2023-03-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
アデノシン核酸塩基編集因子およびそれらの使用
|
|
WO2018027036A1
(en)
|
2016-08-03 |
2018-02-08 |
Dipersio John F |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
WO2018039810A1
(en)
|
2016-08-29 |
2018-03-08 |
Pdi Pharm Development International Ag |
Provision of a therapeutically active cell product
|
|
EP3507366B1
(en)
*
|
2016-09-01 |
2020-10-07 |
ProQR Therapeutics II B.V. |
Chemically modified single-stranded rna-editing oligonucleotides
|
|
EP3509635A1
(en)
|
2016-09-06 |
2019-07-17 |
Vavotar Life Sciences LLC |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
AU2017342543B2
(en)
*
|
2016-10-14 |
2024-06-27 |
President And Fellows Of Harvard College |
AAV delivery of nucleobase editors
|
|
CA3042382A1
(en)
|
2016-11-02 |
2018-05-11 |
Aal Scientifics, Inc. |
Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
|
|
LT3535392T
(lt)
|
2016-11-02 |
2024-04-25 |
Universität Basel |
Imunologiškai atpažįstami ląstelių paviršiaus variantai, skirti naudoti ląstelių terapijoje
|
|
EP3538561A4
(en)
|
2016-11-11 |
2020-10-21 |
The Regents of The University of California |
RNA-GUIDED VARIANT POLYPEPTIDES AND THEIR METHODS OF USE
|
|
CN107043779B
(zh)
|
2016-12-01 |
2020-05-12 |
中国农业科学院作物科学研究所 |
一种CRISPR/nCas9介导的定点碱基替换在植物中的应用
|
|
IL267024B2
(en)
|
2016-12-08 |
2023-12-01 |
Intellia Therapeutics Inc |
Adapted leader RNAs for genomic editing
|
|
MY204487A
(en)
|
2016-12-22 |
2024-08-30 |
Intellia Therapeutics Inc |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
WO2018119354A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Gene editing of pcsk9
|
|
CN106716445B
(zh)
|
2016-12-26 |
2020-10-20 |
深圳市汇顶科技股份有限公司 |
指纹辨识系统
|
|
CN110520163A
(zh)
|
2017-01-05 |
2019-11-29 |
新泽西鲁特格斯州立大学 |
独立于dna双链断裂的靶向基因编辑平台及其用途
|
|
WO2018134787A2
(en)
|
2017-01-20 |
2018-07-26 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of cd137+ cells
|
|
IL267912B2
(en)
|
2017-01-30 |
2023-09-01 |
Univ Leland Stanford Junior |
A genotoxic matching regimen for stem cell transplantation
|
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
|
US20200063127A1
(en)
|
2017-02-15 |
2020-02-27 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
|
BR112019017751A2
(pt)
|
2017-02-28 |
2020-04-07 |
Vor Biopharma, Inc. |
composições e métodos de inibição de proteínas de linhagem específica
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
US12485186B2
(en)
|
2017-03-31 |
2025-12-02 |
The Children's Medical Center Corporation |
Antibody-mediated conditioning with immunosuppression to enable allogeneic transplantation
|
|
CN106916852B
(zh)
*
|
2017-04-13 |
2020-12-04 |
上海科技大学 |
一种碱基编辑系统及其构建和应用方法
|
|
US20210284750A1
(en)
|
2017-04-14 |
2021-09-16 |
Bolt Biotherapeutics, Inc. |
Immunoconjugate Synthesis Method
|
|
BR112019021719A2
(pt)
|
2017-04-21 |
2020-06-16 |
The General Hospital Corporation |
Variantes de cpf1 (cas12a) com especificidade para pam alterada
|
|
JP7364472B2
(ja)
|
2017-05-18 |
2023-10-18 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
標的化された核酸編集のための系、方法、及び組成物
|
|
WO2018213726A1
(en)
|
2017-05-18 |
2018-11-22 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
EP3630970A4
(en)
|
2017-05-25 |
2020-12-30 |
The General Hospital Corporation |
BASIC EDITORS WITH IMPROVED PRECISION AND SPECIFICITY
|
|
IT201700062176A1
(it)
|
2017-06-07 |
2018-12-07 |
Univ Degli Studi Milano |
Metodo per l’isolamento di sottopopolazioni di progenitori cellulari cardiaci e relativi usi in campo medico
|
|
WO2019005886A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS
|
|
AU2018290843B2
(en)
|
2017-06-26 |
2025-04-24 |
Massachusetts Institute Of Technology |
CRISPR/Cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
US10392616B2
(en)
|
2017-06-30 |
2019-08-27 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
|
EP3645721A1
(en)
|
2017-06-30 |
2020-05-06 |
Novartis AG |
Methods for the treatment of disease with gene editing systems
|
|
WO2019018383A1
(en)
|
2017-07-18 |
2019-01-24 |
Calimmune, Inc. |
COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES
|
|
CN111448210B
(zh)
|
2017-07-26 |
2024-05-14 |
四十七公司 |
抗SIRP-α抗体及相关方法
|
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
|
EP3672612A4
(en)
|
2017-08-23 |
2021-09-29 |
The General Hospital Corporation |
GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES WITH MODIFIED PAM SPECIFICITY
|
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
|
US10849924B2
(en)
|
2017-09-26 |
2020-12-01 |
New York Medical College |
Compositions and methods for restoring endothelial glycocalyx
|
|
CN118421665A
(zh)
|
2017-10-06 |
2024-08-02 |
俄勒冈健康与科学大学 |
用于编辑rna的组合物和方法
|
|
KR20200121782A
(ko)
*
|
2017-10-16 |
2020-10-26 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
CA3079141A1
(en)
|
2017-10-17 |
2019-04-25 |
Rhizen Pharmaceuticals Sa |
Crac channel modulators for treating esophageal cancer
|
|
AU2018354189A1
(en)
|
2017-10-24 |
2020-04-23 |
Crispr Therapeutics Ag |
Compositions and methods for the depletion of CD117+ cells
|
|
WO2019084053A1
(en)
|
2017-10-24 |
2019-05-02 |
Magenta Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DEPLOYING CD117 + CELLS
|
|
KR20200069364A
(ko)
|
2017-10-24 |
2020-06-16 |
마젠타 테라퓨틱스 인코포레이티드 |
Cd117+ 세포의 고갈을 위한 조성물 및 방법
|
|
WO2019081982A1
(en)
|
2017-10-26 |
2019-05-02 |
Crispr Therapeutics Ag |
SUBSTANCES AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
|
|
WO2019082124A1
(en)
|
2017-10-26 |
2019-05-02 |
Rhizen Pharmaceuticals Sa |
COMPOSITION AND METHOD FOR THE TREATMENT OF LARGE B-CELL DIFFUSED LYMPHOMA
|
|
EP3703693A1
(en)
|
2017-10-30 |
2020-09-09 |
Rhizen Pharmaceuticals S.A. |
Calcium release-activated calcium channel modulators for treating hematological and solid cancers
|
|
BR112020011167A2
(pt)
|
2017-12-06 |
2020-11-17 |
Rhizen Pharmaceuticals Sa |
composição e método para tratar linfoma de célula t periférico e linfoma de célula t cutâneo
|
|
WO2019113437A1
(en)
|
2017-12-08 |
2019-06-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hematopoietic stem cell engraftment
|
|
CN111712569A
(zh)
|
2017-12-11 |
2020-09-25 |
爱迪塔斯医药公司 |
用于基因编辑的Cpf1-相关方法和组合物
|
|
CN109957569B
(zh)
|
2017-12-22 |
2022-10-25 |
苏州齐禾生科生物科技有限公司 |
基于cpf1蛋白的碱基编辑系统和方法
|
|
US20230193242A1
(en)
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
|
GB201802201D0
(en)
|
2018-02-09 |
2018-03-28 |
Ultrahuman Five Ltd |
Binding agents
|
|
WO2019173654A2
(en)
|
2018-03-07 |
2019-09-12 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
IL277106B2
(en)
|
2018-03-13 |
2024-03-01 |
Amgen Inc |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
EP4321870B1
(en)
|
2018-03-13 |
2025-07-30 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
EP3765617A1
(en)
|
2018-03-14 |
2021-01-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
EP3765614A1
(en)
|
2018-03-14 |
2021-01-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
CA3092148A1
(en)
|
2018-03-19 |
2019-09-26 |
University Of Massachusetts |
Modified guide rnas for crispr genome editing
|
|
WO2019204378A1
(en)
|
2018-04-17 |
2019-10-24 |
The General Hospital Corporation |
Sensitive in vitro assays for substrate preferences and sites of nucleic acid binding, modifying, and cleaving agents
|
|
EP3790964A4
(en)
|
2018-05-11 |
2022-06-08 |
Beam Therapeutics, Inc. |
METHODS FOR REMOVAL OF PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS
|
|
CN112469824A
(zh)
|
2018-05-11 |
2021-03-09 |
比姆医疗股份有限公司 |
利用可编程碱基编辑器系统编辑单核苷酸多态性的方法
|
|
KR20250134703A
(ko)
|
2018-05-11 |
2025-09-11 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 병원성 아미노산을 치환하는 방법
|
|
CN112384230A
(zh)
|
2018-05-14 |
2021-02-19 |
瑟姆巴股份有限公司 |
用于自身免疫障碍的基因编辑
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
CN112566671A
(zh)
|
2018-06-07 |
2021-03-26 |
美真达治疗公司 |
使用抗体药物缀合物(adc)的治疗方法
|
|
KR102894715B1
(ko)
|
2018-08-03 |
2025-12-03 |
빔 테라퓨틱스, 인크. |
핵산 표적 서열을 변형시키기 위한 다중-이펙터 핵염기 편집기 및 이를 이용하는 방법
|
|
EP3841203A4
(en)
|
2018-08-23 |
2022-11-02 |
The Broad Institute Inc. |
CAS9 VARIANTS WITH NON-CANONICAL PAM SPECIFICITIES AND THEIR USES
|
|
EP3843772A2
(en)
|
2018-08-31 |
2021-07-07 |
ALX Oncology Inc. |
Decoy polypeptides
|
|
US12529041B2
(en)
|
2018-09-07 |
2026-01-20 |
Beam Therapeutics Inc. |
Compositions and methods for delivering a nucleobase editing system
|
|
GB201815670D0
(en)
|
2018-09-26 |
2018-11-07 |
Univ Oxford Innovation Ltd |
Protein editing
|
|
CN109295186B
(zh)
|
2018-09-30 |
2023-10-03 |
中山大学 |
一种基于全基因组测序检测腺嘌呤单碱基编辑系统脱靶效应的方法及其在基因编辑中的应用
|
|
US20220034880A1
(en)
|
2018-10-01 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
High specificity and sensitivity immunosorbent diagnostic assays with simultaneous resolution of multiple antibody isotypes
|
|
KR102716514B1
(ko)
|
2018-10-10 |
2024-10-15 |
주식회사 노벨티노빌리티 |
신규 항-c-KIT 항체
|
|
EP3873930A4
(en)
|
2018-10-23 |
2022-12-07 |
Magenta Therapeutics, Inc. |
FC-ALIMINATED ANTIBODY DRUG CONJUGATES (ADCS) AND THEIR USES
|
|
US20200376135A1
(en)
|
2018-10-23 |
2020-12-03 |
Magenta Therapeutics, Inc. |
Fc silenced antibody drug conjugates (adcs) and uses thereof
|
|
CN113301923A
(zh)
|
2018-10-30 |
2021-08-24 |
美真达治疗公司 |
同种异体造血干细胞移植的方法
|
|
AU2019386976B2
(en)
|
2018-11-26 |
2024-05-30 |
Forty Seven, LLC |
Humanized antibodies against c-Kit
|
|
AU2019390394C1
(en)
|
2018-11-28 |
2024-11-28 |
Forty Seven, LLC |
Genetically modified HSPCs resistant to ablation regime
|
|
WO2020113112A1
(en)
|
2018-11-29 |
2020-06-04 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
JP7769544B2
(ja)
|
2018-12-14 |
2025-11-13 |
アムジエン・インコーポレーテツド |
勾配によるタンパク質濃度定量を伴う使用のためのシステム適合性方法
|
|
KR20210121113A
(ko)
|
2019-01-31 |
2021-10-07 |
빔 테라퓨틱스, 인크. |
비-표적 탈아미노화가 감소된 핵염기 편집기 및 핵염기 편집기를 특성규명하기 위한 분석
|
|
US20220136012A1
(en)
|
2019-01-31 |
2022-05-05 |
Beam Therapeutics Inc. |
Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
|
|
WO2020163396A1
(en)
|
2019-02-04 |
2020-08-13 |
The General Hospital Corporation |
Adenine dna base editor variants with reduced off-target rna editing
|
|
AU2020221366A1
(en)
|
2019-02-13 |
2021-08-26 |
Beam Therapeutics Inc. |
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
|
|
WO2020168122A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
US20220235347A1
(en)
|
2019-02-13 |
2022-07-28 |
Beam Therapeutics Inc. |
Compositions and methods for treating hemoglobinopathies
|
|
EP3924478A4
(en)
|
2019-02-13 |
2023-01-25 |
Beam Therapeutics, Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
CN119896751A
(zh)
|
2019-02-13 |
2025-04-29 |
比姆医疗股份有限公司 |
使用腺苷酸脱氨酶碱基编辑器破坏疾病相关基因的剪接受体位点，包括用于治疗遗传性疾病
|
|
WO2020168135A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
WO2020168051A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
JP2022530442A
(ja)
|
2019-04-24 |
2022-06-29 |
マジェンタ セラピューティクス インコーポレイテッド |
アントラサイクリン抗体薬物複合体およびその使用
|
|
SG11202110287QA
(en)
|
2019-04-24 |
2021-10-28 |
Heidelberg Pharma Res Gmbh |
Amatoxin antibody-drug conjugates and uses thereof
|
|
EP3958909A4
(en)
|
2019-04-24 |
2024-01-10 |
Magenta Therapeutics, Inc. |
Anti-cd117 antibody-drug conjugates and uses thereof
|
|
JP2022531141A
(ja)
|
2019-04-24 |
2022-07-06 |
マジェンタ セラピューティクス インコーポレイテッド |
遺伝子治療のコンディショニング方法
|
|
JP2022530443A
(ja)
|
2019-04-24 |
2022-06-29 |
マジェンタ セラピューティクス インコーポレイテッド |
抗ｃｄ１１７抗体薬物複合体およびその使用
|
|
AU2020261405A1
(en)
|
2019-04-24 |
2021-12-23 |
Crispr Therapeutics Ag |
Anti-CD117 antibodies and uses thereof
|
|
WO2020219748A2
(en)
|
2019-04-24 |
2020-10-29 |
Magenta Therapeutics, Inc. |
Anti-cd117 antibodies and uses thereof
|
|
CN110042124A
(zh)
|
2019-04-25 |
2019-07-23 |
国家卫生健康委科学技术研究所 |
基因组碱基编辑增加人红细胞中胎儿血红蛋白水平的试剂盒及应用
|
|
JP2022530100A
(ja)
|
2019-04-25 |
2022-06-27 |
アクティニウム ファーマシューティカルズ インコーポレイテッド |
悪性および非悪性血液疾患の治療のための免疫枯渇の組成物および方法
|
|
CA3140093A1
(en)
|
2019-05-21 |
2020-11-26 |
Beam Therapeutics Inc. |
Methods of editing a single nucleotide polymorphism using programmable base editor systems
|
|
AU2020283811A1
(en)
|
2019-05-24 |
2021-12-16 |
Forty Seven, Inc. |
Regimes for co-administration of immunotherapeutic agents against c-kit and CD47
|
|
US20220313832A1
(en)
|
2019-06-12 |
2022-10-06 |
Ontario Institute For Cancer Research (Oicr) |
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof
|
|
KR102258713B1
(ko)
|
2019-07-31 |
2021-05-31 |
한양대학교 산학협력단 |
사이토신 염기교정용 조성물 및 이의 용도
|
|
EP4003375A4
(en)
|
2019-07-31 |
2023-09-06 |
Forty Seven, Inc. |
DEPLETION DIETS FOR MODIFIED T CELL OR NK CELL THERAPY
|
|
CN120249248A
(zh)
|
2019-08-29 |
2025-07-04 |
比姆医疗股份有限公司 |
用于无毒调理的组合物和方法
|
|
GB201912681D0
(en)
|
2019-09-04 |
2019-10-16 |
Eth Zuerich |
Bispecific binding agent that binds to cd117/c-kit and cd3
|
|
AU2020344547A1
(en)
|
2019-09-09 |
2022-03-24 |
Beam Therapeutics Inc. |
Novel nucleobase editors and methods of using same
|
|
EP3792346B1
(en)
|
2019-09-13 |
2023-07-26 |
Miltenyi Biotec B.V. & Co. KG |
Method for the generation of a cell composition of ventral midbrain dopaminergic progenitor cells
|
|
PT4031569T
(pt)
|
2019-09-16 |
2025-11-12 |
Opsidio Llc |
Anticorpos anti-fator de células estaminais e seus métodos de utilização
|
|
KR20220061241A
(ko)
|
2019-09-17 |
2022-05-12 |
러트거즈,더스테이트유니버시티오브뉴저지 |
표적화된 게놈 변형을 위한 rna-압타머 동원에 의해 매개된 고도로 효율적인 dna 염기 편집기 및 이의 용도
|
|
JP7467610B2
(ja)
|
2019-09-18 |
2024-04-15 |
バイリ－バイオ（チェンドゥ）ファーマスーティカル シーオー．，エルティーディー． |
カンプトテシン誘導体及びその複合体
|
|
EP4017980A4
(en)
|
2019-09-30 |
2024-08-07 |
The Children's Medical Center Corporation |
BCL11A GUIDE AND BASIC EDITOR DISTRIBUTION
|
|
CN114828842A
(zh)
|
2019-10-21 |
2022-07-29 |
理森制药股份公司 |
用于治疗急性髓系白血病的包含dhodh抑制剂的组合物
|
|
NL2024163B1
(en)
|
2019-11-05 |
2021-07-20 |
Univ Of Salamanca |
Means and methods for multiparameter cytometry-based leukocyte subsetting.
|
|
CN114938630A
(zh)
|
2019-11-15 |
2022-08-23 |
尼奥普罗根公司 |
用于心脏修复的永生化心脏干细胞
|
|
EP3825330A1
(en)
|
2019-11-19 |
2021-05-26 |
International-Drug-Development-Biotech |
Anti-cd117 antibodies and methods of use thereof
|
|
KR102772859B1
(ko)
|
2019-11-25 |
2025-02-27 |
주식회사 노벨티노빌리티 |
c-kit에 대한 항체 및 이의 용도
|
|
EP4077652A1
(en)
|
2019-12-20 |
2022-10-26 |
Limagrain Europe |
Improving efficiency of base editing using typev crispr enzymes
|
|
WO2021158921A2
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
US20230108687A1
(en)
|
2020-02-05 |
2023-04-06 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
|
WO2021163587A1
(en)
|
2020-02-13 |
2021-08-19 |
Beam Therapeutics Inc. |
Compositions and methods for engraftment of base edited cells
|
|
CA3174615A1
(en)
|
2020-03-04 |
2021-09-10 |
Suzhou Qi Biodesign Biotechnology Company Limited |
Improved cytosine base editing system
|
|
GB202003129D0
(en)
|
2020-03-04 |
2020-04-15 |
Hansa Biopharma AB |
Conditioning regimen for transplant of stem cells
|
|
US20230183344A1
(en)
|
2020-03-16 |
2023-06-15 |
Magenta Therapeutics, Inc. |
T-cell bispecific binding proteins
|
|
WO2021188840A1
(en)
|
2020-03-19 |
2021-09-23 |
Rewrite Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
EP4132951A4
(en)
|
2020-04-09 |
2025-06-11 |
Verve Therapeutics, Inc. |
CHEMICALLY MODIFIED GENE EDITING GUIDE RNAS WITH CAS12B
|
|
US20230121577A1
(en)
|
2020-04-15 |
2023-04-20 |
The Regents Of The University Of California |
Compositions and Methods for Treatment
|
|
JP2023526007A
(ja)
|
2020-05-13 |
2023-06-20 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
β－ヘモグロビン異常症の処置のための塩基編集アプローチ
|
|
AU2021280943A1
(en)
|
2020-05-27 |
2022-07-28 |
Universität Zürich |
Viral vectors expressing therapeutic proteins specifically in myeloid cells and microglia
|
|
KR20230022211A
(ko)
|
2020-06-08 |
2023-02-14 |
바이리-바이오 (청두) 파마슈티칼 컴퍼니, 리미티드 |
고안정성 친수성 연결 단위를 갖는 캄프토테신 약물 및 이의 접합체
|
|
EP4179079A1
(en)
|
2020-07-10 |
2023-05-17 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
WO2022011458A1
(en)
|
2020-07-13 |
2022-01-20 |
Ontario Institute For Cancer Research (Oicr) |
Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof
|
|
CA3173949A1
(en)
|
2020-07-15 |
2022-01-20 |
LifeEDIT Therapeutics, Inc. |
Uracil stabilizing proteins and active fragments and variants thereof and methods of use
|
|
CA3191729A1
(en)
|
2020-08-14 |
2022-02-17 |
Orchard Therapeutics (Europe) Limited |
Compositions and methods for treating or preventing hereditary angioedema
|
|
AU2021327396A1
(en)
|
2020-08-20 |
2023-03-23 |
Ambrx, Inc. |
Antibody-TLR agonist conjugates, methods and uses thereof
|
|
EP4204098A1
(en)
|
2020-08-29 |
2023-07-05 |
Argenx BV |
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
|
|
JP7719172B2
(ja)
|
2020-09-11 |
2025-08-05 |
ライフ エディット セラピューティクス，インコーポレイティド |
Ｄｎａ修飾酵素並びにその活性断片及びバリアント並びにその使用方法
|
|
JP2023540797A
(ja)
|
2020-09-11 |
2023-09-26 |
メタゲノミ，インコーポレイテッド |
塩基編集酵素
|
|
WO2022081890A1
(en)
|
2020-10-14 |
2022-04-21 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
US12564609B2
(en)
|
2020-10-16 |
2026-03-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hematopoietic stem cell engraftment with a combination of agents
|
|
IT202000028688A1
(it)
|
2020-11-27 |
2022-05-27 |
Consiglio Nazionale Ricerche |
Varianti della citidina deaminasi per l’editazione di basi
|
|
CN114752629B
(zh)
|
2020-12-28 |
2025-08-19 |
华东师范大学 |
一种针对细胞中单个或多个基因进行基因编辑的方法、产品和应用
|
|
EP4274897A4
(en)
|
2021-01-08 |
2025-03-05 |
The General Hospital Corporation |
GENOMEDITING APPROACHES TO THE TREATMENT OF SPINAL MUSCLE ATROPHY
|
|
US20240360414A1
(en)
|
2021-01-15 |
2024-10-31 |
St. Jude Children's Research Hospital, Inc. |
Systems and Methods for Base Editing Of HBG1/2 Gene Promoter and Fetal Hemoglobin Induction
|
|
US20240327859A1
(en)
|
2021-07-02 |
2024-10-03 |
University Of Maryland, College Park |
Cytidine deaminases and methods of genome editing using the same
|
|
US20240352439A1
(en)
|
2021-09-03 |
2024-10-24 |
The University Of Chicago |
Polypeptides and methods for modifying nucleic acids
|
|
CA3232742A1
(en)
|
2021-09-22 |
2023-03-30 |
Andrew M. Bellinger |
Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of disease
|
|
US20230105319A1
(en)
|
2021-09-24 |
2023-04-06 |
Crispr Therapeutics Ag |
PRODRUG INCORPORATED sgRNA SYNTHESIS
|
|
WO2023125814A1
(zh)
|
2021-12-29 |
2023-07-06 |
华东师范大学 |
腺嘌呤脱氨酶及其应用
|
|
CN119013310A
(zh)
|
2022-02-17 |
2024-11-22 |
正序(上海)生物科技有限公司 |
具有改善的编辑精确度的突变的胞嘧啶脱氨酶
|
|
EP4540378A1
(en)
|
2022-06-20 |
2025-04-23 |
CRISPR Therapeutics AG |
Base editing proteins and uses thereof
|
|
CN119585423A
(zh)
|
2022-06-23 |
2025-03-07 |
巴斯夫农业解决方案美国有限责任公司 |
多样化碱基编辑
|